The ACR/CHEST ILD Guidelines in Practice: Watch the Webinar Recording Now!

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: hip OA

Sharing Knowledge to Support Care: A Conversation with ACR Communications & Marketing Committee Member Suleman Bhana, MD, FACR

  |  

Whether he is teaching rheumatologists how to leverage technology tools in their practice or working with the ACR’s Communications and Marketing Committee (CMC) to connect members with practice knowledge and support, Suleman Bhana, MD, FACR, a rheumatologist with Crystal Run Healthcare in Middletown, N.Y., is focused on connecting with his colleagues to improve patient care….

Nonopioid Medication May Be as Effective as Opioids for Chronic Pain

  |  

A recent study compared the efficacy of opioids with nonopioid pain treatments in patients with chronic back pain and hip or knee osteoarthritis. After 12 months, researchers found that treatment with opioids was not superior to treatment with nonopioid medication, with only minor differences in patients’ functional responses to the medications…

Arkansas PBM Bill: A Step in the Right Direction

  |  

During a three-day special legislative session in March, Arkansas Governor Asa Hutchinson (R) signed into law the first bill in the U.S. intended to address a lack of transparency among pharmacy benefit managers (PBMs) and their role in the high cost of prescription drugs.1 The bill, H.B. 1010: Arkansas Pharmacy Benefits Manager Licensure Act, will…

Make Advocacy a Healthy Habit: A Conversation with Christina Downey, MD

  |  

While growing up in California’s capital city, Sacramento, Christina Downey, MD, learned early on that it’s important to speak up for what’s important to her. When she completed her fellowship and joined the ACR in 2015, she found her way to the ACR’s Advocacy 101 program, which trains rheumatologists to become advocates in Washington, D.C.,…

Supply & Demand: Where Will the Rheumatology Workforce Be in 2030?

Arthritis Care & Research  |  

According to the “2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015–2030,” the demand for rheumatologic care is projected to exceed supply of clinical adult rheumatology providers by 4,133 clinical FTEs by 2030. The research now being published estimates the baseline adult rheumatology workforce, as well as determined demographic and geographic factors relevant to the workforce. The research also highlights the need for innovative regional strategies to manage future access to and reduce barriers to care for rheumatology patients in underserved regions…

In Memoriam: Paul A. Bacon, MD

  |  

Paul A. Bacon, MD, professor emeritus of the University of Birmingham’s Department of Rheumatology, died on Jan. 5, 2018. The news of his passing saddened those who had the good fortune to know and collaborate with him. He was admired for his indefatigable dedication to measurement in rheumatic disease, especially vasculitis, as well as to…

Ethics Forum: What to Do When an Autoimmune Patient Needs a Transplant?

W. Blaine Lapin, MD, Jennifer L. Rammel, MD, MPH, & Andrea A. Ramirez, MD, MEd  |  

Despite our best efforts and modern interventions, we still have patients in the intensive care unit with organ failure. Although renal failure can be mitigated by dialysis, patients with cardiac or respiratory failure secondary to active autoimmune disease raise difficult clinical and ethical issues. Two recent cases, both with organ failure, led us to examine…

Dealing with Simultaneous Cancer & Rheumatic Disease

  |  

SAN DIEGO—New insights into how scleroderma and myositis may be linked with cancer have led to intriguing questions that could impact patient care, experts said at the 2017 ACR/ARHP Annual Meeting in November. Understanding the relationship between cancer and rheumatic diseases is important because rheumatologists are seeing more and more patients with both diseases, and…